Clin2
NCT07735728Likely a fitNot yet recruiting

First-in-human study of a new oral drug in healthy volunteers

Healthy Volunteers (HV)

This early-stage trial tests a new oral drug (ZE66-0205) for the first time in healthy people to see how safe it is and how the body handles it. The results will guide future studies for patients.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
32 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • Your body mass index (BMI) is between 18 and 32, and you weigh no more than 100 kg (about 220 lbs).
  • You are generally healthy, with no major medical conditions and no recent surgeries or hospitalizations (within 3 months).
  • You are not a regular smoker (no more than 5 cigarettes a week or equivalent).
  • You can swallow oral medication and are willing to attend multiple study visits and follow the study rules.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07449741Recruiting· Phase 1
Early safety test of HXN6005 in healthy adults

This early-phase study tests an experimental drug called HXN6005 in healthy adults to see how safe it is and how the body handles it. It's looking for volunteers who are generally healthy and meet basic age and weight requirements.

Bayswater, Victoria
NCT07527221Recruiting· Phase 1
Safety study of ZE74-0282 in healthy adults

This is an early-stage safety study testing a new experimental drug called ZE74-0282 in healthy volunteers. Researchers want to learn how safe the drug is and how well people tolerate it before testing it in patients with a disease.

Randwick, New South Wales
NCT07813663Not yet recruiting· Phase 1
Safety study of an experimental oral drug in healthy adults

This study tests a new oral investigational drug in healthy adults to see how safe it is and how the body handles it. It is an early-phase trial that helps determine the right dose and check for side effects.

NCT07580794Recruiting· Phase 1
Safety Study of New Drug HSK56630 in Healthy People

This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.

Bayswater, Victoria
NCT07878481Not yet recruiting· Phase 1
Study of a new oral drug for healthy volunteers

This trial tests a new oral medication in healthy adults to see how safe it is and how the body handles it. It's an early-stage study, so participants help determine the right dose for future patients.

NCT07674940Recruiting· Phase 1
Study of a new drug at different doses in healthy people

This trial tests different doses of a new study drug in healthy people to see how safe it is and how the body handles it. Participation involves taking the drug and having regular check-ups.

Miramar, Florida

Hear when a new Healthy Volunteers (HV) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.